J Biol Chem, Vol. 274, Issue 43, 30849-30857, October 22, 1999
Glycine Insertion in the Hinge Region of Lactose Repressor
Protein Alters DNA Binding*
Catherine M.
Falcon and
Kathleen S.
Matthews
From the Department of Biochemistry and Cell Biology, Rice
University, Houston, Texas 77251
 |
ABSTRACT |
Amino acid alterations were designed at the C
terminus of the hinge segment (amino acids ~51-59) that links two
functional domains within lactose repressor protein (LacI). Gly was
introduced between Gly58 and Lys59 to
generate Gly58+1; Gln60 was changed to Gly or
Pro, and up to three additional glycines were inserted following
Gln60
Gly. All mutant proteins exhibited purification
behavior, CD spectra, assembly state, and inducer binding properties
similar to wild-type LacI and only small differences in trypsin
proteolysis patterns. In contrast, significant differences were
observed in DNA binding properties. Gly58+1 exhibited a
decrease of ~100-fold in affinity for O1 operator, and
sequential Gly insertion C-terminal to Gln60
Gly
resulted in progressively decreased affinity for O1
operator, approaching nonspecific levels for insertion of
2 glycines.
Where sufficient affinity for O1 operator existed,
decreased binding to O1 in the presence of inducer
indicated no disruption in the allosteric response for these proteins.
Collectively, these results indicate that flexibility and/or spacing
between the core and N-terminal domains did not significantly affect
folding or assembly, but these alterations in the hinge domain
profoundly altered affinity of the lactose repressor protein for its
wild-type target sequence.
 |
INTRODUCTION |
The lac repressor (LacI) negatively regulates
lac mRNA synthesis by binding with high affinity to its
target operator site and thereby precluding transcription by RNA
polymerase (1-6). In response to the presence of inducer sugars, LacI
undergoes a conformational change that results in diminished affinity
for operator sequences without effect on nonspecific DNA binding (1, 2,
7). LacI is a protein of 150,000 Da composed of four identical subunits
assembled as a dimer of dimers (see Fig. 1) (7-10). The N-terminal 60 amino acids in each monomer form a helix-turn-helix motif that directly
contacts the operator DNA (7, 11-17). When isolated, this region
exhibits site-specific DNA binding, albeit with significantly lower
affinity than the intact protein (11, 18, 19). The LacI core domain
consists of residues 60-360, which encompass the inducer-binding site
and the assembly determinants for the protein (7, 10, 20-30).
The binding of inducer to the core domain results in disruption of
specific DNA binding (1, 2), apparently because of structural shifts
transmitted to the N termini that alter their relative orientation and
thereby preclude complementarity with the operator sequence (7, 26,
27). Assembly to tetramer is mediated by two separate regions:
(a) a monomer-monomer interface that is generated by
contacts throughout the core domain primary sequence and (b)
a dimer-dimer interface formed by a short segment at the C terminus of
the protein (amino acids ~340-360) that assembles via a leucine
heptad repeat sequence into a 4-helical anti-parallel coiled-coil
structure (7, 10, 21-30).
The N-terminal DNA-binding domain has been studied extensively by NMR
spectroscopy, an approach necessitated by the inability to discern
electron density for the N-terminal domain in the crystal form without
operator present (7, 10, 13-17, 31, 32). This DNA-binding domain has
considerable structure when isolated from the remainder of the protein,
and this region remains remarkably mobile even when attached to the
larger and more rigid core domain (33). The segment that covalently
connects the N-terminal DNA-binding domain to the tetrameric core
protein is the hinge formed by amino acids 51-59, and flexibility in
this region may contribute to the observed N-terminal freedom of
motion. The proteolytic susceptibility of this region was ascribed to
the absence of stable secondary structure, consistent with the motional
flexibility of the attached N-terminal DNA-binding domain (18, 19,
33-36). The large
Cp observed for LacI-operator binding
has been attributed to a local folding transition in the protein that
buries apolar residues, a process potentially corresponding to hinge
helix formation (37). The folded hinge region in the crystal structure
of LacI bound to a symmetric operator DNA appeared to confirm this
interpretation (7). In addition, NMR analysis demonstrated helix
formation by the hinge region in isolated N-terminal domains when
complexed with full-length operator but not in the free state (31).
Similarly, the hinge helix of the LacI homolog, PurR, occurs only in
the presence of the cognate operator sequence (38, 39). In contrast to
LacI, folding of the PurR hinge helix is not observed for the isolated
PurR N-terminal DNA-binding domain, even in the presence of specific
DNA sequences (40). Whether this difference derives from the distinct
effects of effector ligand (corepressor versus inducer) or
other sources is not yet established. DNA binding in other proteins has
been shown to involve
-helix formation from an unfolded segment in
conjunction with complex formation (41-43). Thus, protein recognition
of site-specific DNA appears in many cases not to be an interaction
between rigid bodies but rather involves coupled changes in the
structure of the protein (37) and potentially in the DNA (44).
The significance of the small hinge region that links the N terminus
and core domains to overall LacI function has motivated a more detailed
analysis of this flexible segment. Extensive genetic studies on the
LacI gene have demonstrated that multiple substitutions within the
hinge diminish operator binding (26, 27, 45, 46). Based on proteolytic,
crystallographic, and NMR studies, the hinge region assumes structure
in the presence of DNA, and this connecting segment may therefore be
important for the allosteric transition that effects communication of
operator and inducer binding (7, 26, 27, 33, 47, 48). To explore the
contribution of the hinge segment to DNA recognition and to allosteric
communication within LacI, we have altered flexibility and/or spacing
within this region. Glycines are found at turns and bends of a folded protein structure and are presumed to be flexible at least in part
because of the absence of a side chain (49, 50). We have therefore made
a series of mutations in the hinge region that either alter a single
amino acid side chain or introduce one or more additional glycines into
the amino acid sequence at selected sites (see Table I and Fig.
1B). The results obtained with
these mutant proteins indicate that high affinity DNA binding is
closely coupled with the sequence of the hinge region and that precise orientation appears important for optimal interaction of this regulatory protein with its cognate operator sequence.

View larger version (43K):
[in this window]
[in a new window]
|
Fig. 1.
Structure of LacI complexed with DNA and
structure of hinge region within a dimer. A, the
structure of LacI complexed with DNA was derived from PDB file 1LBG (7)
and was rendered using Ribbons (74) and Pixar's Renderman. The
N-terminal DNA-binding domains (residues 1-61 per monomer) are
dark gray to show the interaction with DNA
(space-filled) and their orientation in relation to the core
domain (light gray). B, two N termini within a
dimer are isolated from the remainder of the protein. Residues 58 and
60 are at the C-terminal end of the hinge helices and are highlighted
to show the position at which insertion mutations were made. The view
is looking at the protein surface from the DNA.
|
|
 |
MATERIALS AND METHODS |
Bacterial Cells and Growth--
Bacterial strain
Escherichia coli DH5-
(F'/endA1hsdR17(rk
mk
)
supE44 thi-1recA1
gyrA(NaIr) relA1
(lac IZYA-argF)U169deoR(
80dlac
(lacZ)M15) was used for DNA purification. Proteins were
expressed using E. coli BL26 cells (BL26Blue cells from
Novagen (Madison, WI), which are ompT hsdSB
(rB
mB
) gal dcm
lac[F'proABlacIqZ
M15::Tn10(TcR)]), which had been
cured of the episome that carries the Iq promoter and the I
gene.1 Cells were grown in 2 × YT medium (16 g/liter tryptone, 10 g/liter yeast extract, and 5 g/liter NaCl, pH 7.4) for liquid culture. LB medium (10 g/liter
tryptone, 5 g/liter yeast extract, and 10 g/liter NaCl, pH 7.4) with 15 g/liter agar was used for plates. Selection antibiotics were present at
50 µg/ml for a final concentration.
Site-specific Mutagenesis--
Mutations in the lac
repressor were generated on plasmid pJC1 (25) using the Chameleon
mutagenesis protocol from Stratagene. The mutagenic and selection
oligonucleotides (Great American Gene Co. or Genosys) were used at
least 100-fold concentration over template. The mutagenesis mixture was
transformed into E. coli XLmutS cells (Stratagene) or
E. coli mutS cells (Promega) that were subsequently grown
overnight in 5 ml of 2 × YT. Plasmid DNA was purified and examined by
restriction digestion. Following retransformation into E. coli DH5-
cells, individual colonies were selected for growth
and purification of plasmid DNA. Plasmid DNAs from individual colonies
that digested with the selection enzyme were sequenced to determine
whether they also carried the mutation. Plasmids carrying the
appropriate mutation were sequenced in their entirety to confirm that
the designed change was the only alteration in sequence present.
Protein Purification--
Purification of lactose repressors
followed the previously described procedure for wild-type protein (51,
52), with some modifications. The cell lysis supernatant was
precipitated with 40% ammonium sulfate and allowed to incubate at
4 °C for at least 30 min. The pellet was resuspended in buffer
containing 0.09 M potassium phosphate, pH 7.5, 5% glucose,
0.3 mM dithiothreitol. This solution was then dialyzed
overnight at 4 °C against the same buffer. The dialyzed fraction
containing the lac repressor protein was centrifuged at 9000 rpm for 30 min to remove any precipitate before loading onto a
phosphocellulose column equilibrated with 0.09 M potassium
phosphate, pH 7.5. After loading the protein suspension, the column was
washed with the same buffer, followed by 0.12 M potassium
phosphate buffer, and then eluted with a gradient from 0.12 to 0.3 M potassium phosphate. Fractions containing the lac repressor protein were collected, and concentrations
were determined using absorbance at 280 nm, using wild-type
lac repressor as a standard. Throughout purification and
isolation, the protein activity was detected by the
[14C]IPTG2
assay described by Bourgeois (53) using the buffer, 0.1 M
Tris-HCl, pH 7.4, and 0.15 M KCl.
Circular Dichroism Measurements--
Wild-type lac
repressor and mutant proteins were examined by circular dichroism using
an Aviv 62DS spectropolarimeter with a 2-mm-path length quartz cuvette.
Protein concentration was 4 × 10
6 M
monomer in 0.12 M potassium phosphate buffer, pH 7.6. Samples were scanned from 250 to 200 nm, and data were compared with
the spectrum for wild-type lac repressor.
Molecular Weight Determination--
Wild-type lac
repressor and mutant proteins were subjected to molecular sieve
chromatography using a Superose 12 column equilibrated in 50 mM Tris-HCl, 200 mM KCl buffer, pH 7.6. Elution
volume was determined by monitoring absorbance at both 230 and 280 nm.
All mutant proteins eluted at the same volume as determined for
wild-type lac repressor.
Proteolysis of Protein--
Individual proteins were diluted to
0.3 mg/ml in 1 M Tris-HCl, pH 7.6, 30% glycerol at room
temperature. Trypsin (1 mg/ml in 1 mM HCl) was added to
obtain a 2% (w/w) final solution (18). An aliquot of undigested
protein was removed prior to trypsin addition. Digestion was carried
out at room temperature, samples were taken at designated time points,
and further digestion was inhibited with addition of 4% (w/v)
phenylmethylsulfonyl fluoride (4 mg/ml in 100% EtOH). Samples were run
on 10% SDS-polyacrylamide gel electrophoresis to visualize digestion patterns.
Repressor-Inducer Binding--
Binding of inducer was assessed
by monitoring the change in fluorescence emission intensity (54). The
protein concentration for wild-type lac repressor and all
mutants was 1.5 × 10
7 M monomer. The
final inducer concentrations ranged from 6.7 × 10
8
M to 1.8 × 10
4 M for assays
done at pH 7.6 and from 1.3 × 10
7 M to
4.4 × 10
4 M for assays done at pH 9.2. Proteins were diluted into 0.01 M Tris-HCl, 0.15 M KCl buffer at the specified pH. The fluorescence emission
was monitored on an SLM-Aminco 8100 spectrofluorometer using a 340-nm
cut-off filter (O-52) from Corning with an excitation wavelength of 285 nm (55, 66). Fluorescence intensity correction factors for dilution and
photobleaching were generated using an identical titration with buffer
solution rather than IPTG. Data were analyzed by nonlinear least
squares analysis to fit to the binding equation,
|
(Eq. 1)
|
where R is fractional saturation (change in
fluorescence signal at a particular IPTG concentration divided by the
maximum change in fluorescence signal), Ym is a
factor that allows the maximum value of R to float,
Kd is the apparent equilibrium dissociation
constant, and n is the Hill coefficient.
IPTG titrations for selected proteins were also performed in buffer at
pH 7.6 in the presence of near saturating amounts of specific operator
sequences to assess the effect on inducer affinity. Protein
concentrations were 1.5 × 10
7 M
monomer. The final IPTG concentrations were varied. The operator concentration was 5.0 × 10
7 M.
Repressor-Operator Binding--
A 40-base pair double-stranded
DNA corresponding to the wild-type O1 operator
(5'-TGTTGTGTGGAATTGTGAGCGGATAACAATTTCACACAGG-3') was used to measure
operator affinity for the mutant proteins. The oligonucleotides (Great
American Gene Co.) were purified by polyacrylamide gel electrophoresis
and eluted from the gel by incubation overnight in TE buffer at
37 °C with gentle agitation. The top and bottom strands were
hybridized in annealing buffer (8 mM Tris-HCl, pH 7.5, 4 mM MgCl2, 10 mM NaCl), and this
material was labeled at the 5' end with 32P by
polynucleotide kinase reaction. A Nick column (Amersham Pharmacia Biotech) was used to purify the labeled 40-base pair operator from the
free nucleotides after the reaction was completed.
Operator binding was assayed using the nitrocellulose filter binding
assay (51, 56) modified for use in a 96-well dot blot apparatus (57).
The assay was performed at room temperature in buffer containing 0.01 M Tris-HCl, pH 7.6, 0.1 mM EDTA, 0.15 M KCl, 5% dimethyl sulfoxide. The proteins were diluted
into this buffer with the addition of 50 µg/ml bovine serum albumin.
The concentration of labeled operator used in the assay was 1.3 × 10
13 M for tight-binding mutants, 1.0 × 10
12 M for normal binding, and 1.0 × 10
10 M for low affinity binding. The
concentration of protein ranged from 1.0 × 10
13
M to 1.0 × 10
6 M tetramer
depending upon the affinity of the repressor for operator. The amount
of 32P-labeled operator bound at the various protein
concentrations was quantified using a Fugi phosphorimager. All data
were normalized by dividing the pixels at the various protein
concentrations by the pixels at a saturating concentration of protein
with operator. These data were fit to Equation 2,
|
(Eq. 2)
|
where R is the fraction of operator in complex,
Ym is a correction factor that allows the maximum
value of R to float, [P] is the protein
concentration in tetramer, and Kd is the apparent
dissociation constant in tetramer concentration. Some binding curves
did not reach saturation even at maximal protein concentrations, and
therefore the Kd values derived from these curves
are only approximate. Nonspecific binding for lac repressor
mutant proteins was determined by the addition of IPTG to
10
3 M and by using a sequence
(5'-TGTTGTGTGGAGACATGCCTAGACATGCCTTTCACACAGG-3') to which wild-type
LacI binds with affinity comparable to that observed with operator DNA
in the presence of IPTG. The data were collected and analyzed as described.
Release of operator DNA in the presence of inducer was measured.
Protein was mixed with labeled operator (1 × 10
12
M), and protein concentrations were those determined from
the repressor·operator binding assays to generate ~80% complex
formation. The concentration of IPTG varied from 2 × 10
7 M to 2 × 10
4
M. Once inducer was added, the reaction mixture was allowed
to incubate at room temperature for 20-30 min and then was filtered onto nitrocellulose. The amount of 32P-labeled operator
bound at the various IPTG concentrations was quantified using a Fugi phosphorimager.
 |
RESULTS AND DISCUSSION |
Rationale for Mutagenesis and Production of Mutant
Proteins--
Genetic studies suggested that
Gly58-Lys59 at the C terminus of the LacI hinge
helix may be important for DNA binding (45, 46), and other analyses
have expanded this view (58, 59). The ends of an
-helix are
important to stabilize the structure and "cap" the end of the helix
(60-62), and glycines are commonly found in the sequence of C-terminal
caps (63, 64). Moreover, lysines are sometimes found at the C terminus
of an
-helix, because the positive charge can interact with the
helix dipole and the long side chain can fold back to stabilize the
conformation via hydrophobic interactions (64, 65). Inspection of the
hinge helix in LacI suggests that Gly58 may be involved in
such a cap and that Lys59 may play a role in stabilizing
the hinge helix (Table I). Thus, insertion of additional glycines between these two amino acids might
disrupt the conformation of the entire region. For the first mutation,
an oligonucleotide was designed to incorporate an extra glycine that
was C-terminal to Gly58 (Gly58+1), separating
Gly58-Lys59. Position 60, at the C-terminal end
of the hinge region, is tolerant to different amino acids based on
phenotype from genetic studies and presumably therefore does not have a
structural role in the hinge helix or in LacI function (26, 27, 45,
46). This position was therefore chosen as an alternative site for
glycine substitution and insertion. In a second series,
Gln60 was mutated to glycine (Gln60
Gly),
and then, sequentially, glycines were inserted to generate a second
series of glycine insertions (Table I). As an alternate substitution,
Gln60
Pro was used to assess the effect of minimized
conformational flexibility on function. Proline constrains the peptide
backbone, thus making the polypeptide chain locally less flexible
(49).
Following double-stranded mutagenesis to introduce designed changes in
DNA sequence, the plasmids for each mutation were sequenced throughout
the lacI gene to verify the desired change and to confirm the absence of other DNA sequence alterations. These constructs were
then transformed into E. coli BL26 cells for protein
expression. The proteins were all expressed at high levels and were
purified readily according to the protocol for the wild-type repressor protein (see Fig. 4 for gel electrophoresis results).
Secondary Structure and Assembly of Mutant Proteins--
The
purification properties of the mutant repressors suggested that they
possess structure similar to the wild-type protein. To confirm this
conclusion, circular dichroism measurements were used to demonstrate
that the secondary structure content for all of the mutant proteins was
similar to wild-type LacI (Fig. 2). Furthermore, all of the mutant proteins eluted at a volume similar to
wild-type LacI from molecular sieve columns (data not shown), indicating that the oligomeric structure was also wild type in nature.
Thus, none of this series of mutant proteins exhibited folding or
assembly characteristics distinct from wild-type lac repressor.

View larger version (31K):
[in this window]
[in a new window]
|
Fig. 2.
Circular dichroism spectra for wild-type and
mutant lac repressors. The circular dichroism
spectra were measured as described under "Materials and Methods."
The protein concentration was 0.15 mg/ml in 0.12 M
potassium phosphate buffer, pH 7.6. Spectra are shown for wild-type
LacI ( ), Gly58+1 ( ), Gln60 Gly ( ),
Gln60 Pro ( ), Gly60+1 ( ),
Gly60+2 ( ), and Gly60+3 ( ).
|
|
Inducer Binding Properties--
Similarly, inducer binding at pH
7.6 was observed to be very similar to wild-type LacI for all of the
mutant proteins in this series (Table II
and Fig. 3). Thus, the tertiary fold of
the monomer required for contacting the sugar within its binding site
was maintained in all of the mutant proteins. At pH 9.2, wild-type LacI
exhibits a lower affinity for IPTG and shows cooperativity in binding
under these conditions (25, 67). This pH-dependent behavior
mimics the response seen when IPTG binding is assayed in the presence
of saturating amounts of operator and relies on the integrity of the
monomer-monomer interface (25, 55, 67). When assayed at elevated pH,
all the mutant proteins demonstrated similar binding affinities to
wild-type lac repressor. Thus, communication between the
subunits within a dimer, reflected in the pH-dependent behavior for inducer binding (25), is not influenced by the hinge
segment mutations. These data demonstrate that the core domain, which
must fold effectively to form the inducer-binding site, is intact in
the mutant proteins and that the monomer-monomer subunit interface
necessary for cooperativity also is unaffected by these mutations.

View larger version (34K):
[in this window]
[in a new window]
|
Fig. 3.
Inducer binding curves for mutant
proteins. Fluorescence titrations were performed on an SLM 8100 spectrofluorometer as described under "Materials and Methods." The
concentration of protein was 1.5 × 10 7
M monomer in 0.01 M Tris-HCl, 0.15 M KCl at the indicated pH. Assays were performed at pH 7.6 ( ) and pH 9.2 ( ). The curves were generated by simultaneously
fitting all the data to Equation 1. Three replicates were included for
each assay condition.
|
|
Proteolysis of Mutant Proteins--
Mild proteolysis of wild-type
LacI has been shown to be very specific under certain solution
conditions and proceeds to only a limited extent (18, 34-36). This
phenomenon presumably results from folding of a specific region to
occlude an otherwise susceptible bond that consequently becomes
resistant to cleavage (68). With mild proteolytic digestion of
lac repressor, the DNA-binding domain is separated from the
inducer-binding domain with loss of high affinity operator recognition
(18, 19, 34, 69). Trypsin cleavage was found to occur following amino
acids Arg51 and Lys59, which flank the hinge
sequence (18, 19, 35, 36). The mutant proteins generated in this study
were assessed by mild trypsin digestion to determine whether the amino
acid changes or additional glycines rendered the hinge region altered
in protease susceptibility compared with wild-type LacI (Fig.
4). From these experiments, the insertion
mutants exhibited approximately the same digestion products as
wild-type lac repressor. The wild-type protein was ~50%
digested within ~30 min. Gln60
Gly,
Gly60+1, and Gly58+1 had comparable digestion
patterns to wild-type protein. Gly60+2 and
Gly60+3 demonstrated slightly accelerated digestion,
presumably a result of the additional flexibility and/or accessibility
of the target region. Gln60
Pro was digested by trypsin
at a decreased rate compared with wild-type protein and to a larger
product, a result derived at least in part from decreased
susceptibility of the scissile peptide bond when a proline follows a
lysine (70). The small population of lower molecular weight bands may
be a result of C-terminal digestion (18, 36). Based on these results,
the hinge region does not appear to be significantly altered in its
solvent/protease exposure by the amino acid changes introduced in
the hinge region.

View larger version (96K):
[in this window]
[in a new window]
|
Fig. 4.
Trypsin digestion of mutant proteins.
The proteins were diluted to a final concentration of ~0.3 mg/ml in 1 M Tris-HCl, pH 7.6, 30% glycerol and digested with trypsin
(2% w/w) at room temperature for the indicated times in minutes.
Digestion was terminated with the addition of phenylmethylsulfonyl
fluoride (4% w/v). The samples were electrophoresed on
SDS-polyacrylamide gels (10%) and silver-stained to visualize the
products. The digestion times are designated (in minutes). The
arrows point to the undigested protein (higher molecular
weight band) and the digested product (lower molecular weight
band).
|
|
Operator DNA Binding Properties--
This series of proteins was
assayed using the wild-type primary operator sequence, O1
(Table II and Fig. 5). For the
Gly58+1 protein, significant loss of binding affinity was
observed, with a Kd of 1.5 × 10
9
M for O1 compared with 1.2 × 10
11 M for wild-type LacI. In sharp contrast,
the substitution mutant, Gln60
Gly, had a higher
affinity for O1 compared with wild-type protein, with a
Kd of 4 × 10
12 M.
With sequential glycine insertion following Gly60, the
affinity for O1 decreased until the Kd
approached that for nonspecific DNA binding, >1 × 10
7 M (70). Gln60
Pro
exhibited only a 6-fold reduced affinity for O1 compared
with wild-type LacI. Although increasing flexibility in
Gln60
Gly increased affinity, increasing the
"rigidity" of this region in Gln60
Pro appeared to
impair recognition of the operator sequence but only moderately.
Wild-type and mutant proteins were assayed with a nonspecific DNA
sequence, and the equilibrium dissociation constant was
>10
7 M (Table II, footnote c) (71). The
binding to nonspecific DNA for the mutant proteins appeared unaltered
compared with the wild-type protein.

View larger version (36K):
[in this window]
[in a new window]
|
Fig. 5.
Operator binding curves for mutant
proteins. The concentration of labeled DNA was 1 × 10 13 M for Gln60 Gly and
1 × 10 12 M for wild-type LacI and all
others, except for assays with Gly60+3 where the DNA
concentration was increased to 1 × 10 10
M. The protein concentration in tetramer varied as
indicated. Fractional saturation ( ) was determined as the ratio of
labeled DNA retained by the filter for a specific concentration of
protein to labeled DNA retained at saturating protein concentrations,
after subtracting the retention of DNA in the absence of protein. Each
assay was repeated at least in triplicate, and the curves indicated by
the lines were generated by simultaneously fitting all the
data to Equation 2. Fractional saturation in the presence of 1 mM IPTG ( ) was determined by normalizing labeled DNA
retained in the presence of inducer to the saturating value for
operator alone to allow comparison of these binding curves.
|
|
The diminution in DNA binding observed in Gly58+1 and in
Gly60+1, Gly60+2, and Gly60+3 may
derive from several effects of these alterations: (a) The entropic cost of binding anticipated to accompany the increased flexibility derived from Gly substitutions may exact an increasing cost
in the protein-operator interaction as the number of Gly residues
increases. (b) An effect on hinge helix folding by the substitutions may compromise affinity. (c) Misalignment of
the operator half-sites with the two N-terminal DNA-binding domains within a dimer may be elicited by alterations in N-terminal·core spacing with the consequence of diminished DNA binding affinity. (d) Essential interactions between the N-terminal and core
domains may be disrupted by these hinge alterations. Each of these
factors may contribute differentially to the observed effects on each mutant protein. Distinguishing these effects will require further exploration of these mutants.
Release of Operator by IPTG--
The importance of the hinge helix
in transmitting the induction signal between the sugar-binding site in
the core domain and the N-terminal DNA-binding domain has been
suggested (7, 26, 27, 34, 47, 48). To explore the effect of inducer on
operator binding for this series of mutants, O1 affinity in
the presence of IPTG was determined (Fig. 5). Operator binding was
diminished for all the mutant proteins in the presence of saturating
amounts of inducer; a difference was apparent even for
Gly60+3, for which binding approached nonspecific levels.
This result demonstrated directly that the allosteric response was not
disrupted in these mutant proteins, even when DNA binding was severely
diminished. Gln60
Pro, with presumably increased
rigidity in this region, also demonstrated a significant decrease in
affinity in the presence of saturating amounts of inducer, suggesting
that constraining this region inhibits optimal operator recognition but
does not affect the allosteric response.
To quantitate the release of DNA by the presence of IPTG, an additional
assay was employed to examine those mutants with high affinity for
operator. To a preformed repressor·operator complex, increasing
amounts of IPTG were added to elicit release of the operator, that is,
the decrease in operator binding will reflect the allosteric response
to inducer binding. The release patterns for wild-type and the
Gln60
Gly and Gly60+1 proteins are very
similar, whereas Gly60+2, which has the lowest operator
binding affinity of the proteins examined, appears to release operator
at lower IPTG concentrations (Fig. 6).
Gln60
Pro and Gly58+1 respond to inducer
when bound to operator, even though they demonstrate lower affinity to
operator compared with wild-type LacI. These data provide further
confirmation that these mutant proteins maintain allosteric
communication.

View larger version (35K):
[in this window]
[in a new window]
|
Fig. 6.
Release of operator by mutant proteins.
Protein concentration was 1 × 10 9 M for
Gln60 Gly, 5 × 10 9 M
for wild-type LacI, 5 × 10 8 M for
Gly60+1 and Gln60 Pro, 1 × 10 7 M for Gly60+2, and 5 × 10 7 M for Gly58+1. DNA
concentration was 1 × 10 12 M. Each
protein was mixed with operator and incubated at room temperature for
20 min. Varying concentrations of IPTG were added from 2 × 10 7 M to 1 × 10 4
M. The protein·operator complexes were filtered through
nitrocellulose, and retained counts were quantitated. The
lines are drawn only to facilitate comparison. Wild type
( ), Gly58+1 ( ), Gln60 Gly ( ),
Gly60+1 ( ), Gly60+2 ( ), and
Gln60 Pro ( ).
|
|
Operator DNA Effects on Inducer Binding--
To explore the
thermodynamic cognate of inducer effects on operator affinity, we have
measured the binding of inducer in the presence of saturating amounts
of operator DNA. Operator DNA diminished inducer affinity for wild-type
protein, as observed previously (55, 67). For the mutant proteins with
high operator affinity, behavior similar to that of the wild-type
protein was observed (Fig. 7). The higher
differential for operator binding in the presence and absence of IPTG
for Gln60
Gly is reflected in the IPTG binding behavior
in the presence of operator, with a greater decrease in IPTG affinity
with O1 presence compared with the wild-type protein.
Gln60
Pro and Gly60+1 binding exhibit a
differential for IPTG binding with/without O1 operator
slightly lower than for wild-type LacI, consistent with their slightly
diminished operator affinity and consequent lower differential for
O1 binding with/without IPTG. Gly58+1,
Gly60+2, and Gly60+3 exhibited a smaller shift
for inducer binding in the presence of O1 operator, as
anticipated from their DNA binding behavior. Inducer affinity in the
presence of operator increases, and the differential with/without
operator decreases with the number of glycine insertions at
Gln60
Gly, with almost complete loss of communication
when three extra glycines are inserted in Gly60+3. Thus, as
the differential between specific and nonspecific DNA binding
diminishes, the effect of operator on inducer affinity also decreases.
Thus, the thermodynamic cycle for binding of inducer and operator is
preserved in these mutant proteins, and the only detectable effect of
mutation is alteration in the operator DNA affinity. These results
underscore the importance of the hinge segment in determining the
affinity for and potentially even recognition of specific DNA
sequences.

View larger version (33K):
[in this window]
[in a new window]
|
Fig. 7.
Inducer binding curves in the presence of
O1 operator DNA. Fluorescence titrations were
performed on an SLM 8100 spectrofluorometer as described under
"Materials and Methods." Inducer binding was measured in the
absence of operator ( ) and in the presence of 5 × 10 7 M operator ( ]). The concentration of
protein was 1.5 × 10 7 M monomer in 0.01 M Tris-HCl, 0.15 M KCl at pH 7.6. The curves
were generated by simultaneously fitting all the data to Equation 1.
Three replicates were included for each assay condition.
|
|
Conclusions--
Evidence from genetic studies (27, 45, 46),
x-ray crystallographic structures (7), and NMR experiments (31)
have combined to demonstrate conclusively that the hinge segment of LacI is involved in DNA binding. This region is the only covalent linkage between the N-terminal DNA-binding domain and the core inducer-binding domain of the protein. Introduction of an additional Gly residue following Gly58 (Gly58+1) resulted
in a significant decrease (~100-fold) in operator affinity, whereas
conversion of Gln60 to Gly increased binding to DNA. Thus, the specific
site at which flexibility/spacing is introduced is crucial for high
affinity operator binding. Gly58 is within the hinge helix,
and alteration of the sequence and/or spacing at the C terminus of the
hinge, perhaps by interfering with a helix cap, may impede formation of
the hinge helix and thereby diminish DNA binding affinity. However,
limiting the mobility of the backbone by the mutation Gln60
Pro decreased O1 operator DNA binding by only
~6-fold, and addition of a Gly to Gln60
Gly
(Gly60+1) decreased operator binding compared with
wild-type LacI by <4-fold. These changes in the hinge sequence
therefore affected binding to O1 operator only minimally.
In contrast, addition of further Gly residues to Gly60+1
disrupted DNA binding significantly, with a ~104
difference between Gln60
Gly and Gly60+3
binding affinity. Interestingly, the allosteric response to inducer was
unaffected in this series of mutant proteins; the addition of inducer
diminished binding for all of the mutants.
The only property affected significantly by these mutations in the
hinge domain of the protein was binding to O1 operator DNA.
The purification parameters, inducer binding properties, molecular
mass, folding as assessed by circular dichroism, and sensitivity to
protease were all comparable with those of the wild-type protein. Thus,
mutation in the hinge region does not exert significant influence
outside this domain, in contrast to other mutations that have long
range effects on structure and function (28, 29, 30, 72). The exclusive
effect of the mutations examined in the hinge segment is on operator
DNA binding. Furthermore, all the mutant proteins exhibit allosteric
response to inducer binding, and, consistent with thermodynamic
principles, the extent to which the presence of O1 operator
DNA diminished inducer binding correlated directly with the
allosteric effect of IPTG on operator binding.
The specific mechanism by which introduction of additional
flexibility/spacing in the hinge region reduces specific operator recognition, as observed in particular for Gly58+1,
Gly60+2, and Gly60+3, cannot be unequivocally
deduced from the current information. At least four potential
contributions to disruption of binding can be identified. Increased
flexibility in the region linking the core and DNA-binding domains may
(a) increase the entropic cost of binding and thereby
diminish affinity; (b) alter the spacing of the N-terminal
DNA-binding domains with respect to one another within a dimer and
therefore preclude formation of the high affinity DNA-binding site;
(c) affect folding of the hinge helix required for minor
groove insertion; or (d) affect the ability of the
N-terminal DNA-binding domain to interact with the core domain, an
arrangement potentially required for alignment of the N termini and
consequently DNA binding. The hinge alterations generated in LacI could
influence any of these factors.
At least one of these factors appears important for binding of PurR to
its operator DNA. A recent demonstration that the binding of the LacI
homolog, PurR, to operator DNA can be disrupted by mutation at core
residue Arg115, which appears to form a hydrogen bond with
the backbone of Ser46' in the partner subunit N
terminus, suggested that N-terminal·core interactions may be
important in PurR DNA binding and/or allostery (73). Of note in this
context is the effect of substitution at Arg118, the
homologous residue in LacI; phenotypic measurements indicate that
substitution of this residue results in protein unable to bind
effectively to operator in vivo (26, 27, 45, 46). Whether
alterations in the hinge domain affect core·N-terminal interactions
or alter the three-dimensional arrangement of the N-terminal, hinge,
and core domains will require crystallographic structural analysis of
these mutant proteins. What is evident, however, from comparing the
data for Gly60+1 and Gly60+2 or for wild type
and Gly58+1 is that lengthening the polypeptide backbone
that connects the N terminus and core domain in lactose repressor
protein can have a profound effect on O1 operator DNA
binding parameters. Despite the significant changes in O1
operator affinity, insertion of additional amino acids did not disrupt
the allosteric response. From the crystallographic structures (7),
inducer binding elicits a conformational change that shifts amino acid
62 ~3.5 Å away from its partner within the dimer. This structural
shift presumably disrupts hinge helix interaction with DNA and may
preclude hinge helix folding. The separation of N-terminal DNA-binding
domains and potential loss of the hinge helix would abolish high
affinity specific binding. Insertion of glycine residues adds
additional "distance" between the N-terminal DNA binding and core
inducer-binding domains with the consequence of significant loss in
O1 binding affinity but maintenance of inducibility.
Thermodynamic studies are underway to assess the entropic contribution
to binding, and these measurements may indirectly assess effects on
hinge helix folding based on derived
Cp values.
The hinge region of the LacI protein is key to the DNA binding activity
of the tetramer, and recognition of the primary operator sequence is
influenced significantly by specific alterations in this segment that
increase flexibility and/or extend the polypeptide backbone. The
ability to specifically modify DNA binding alone, while maintaining the
structure and other binding properties of the protein, provides an
opportunity to explore the role of DNA sequence and structure in a
varied background of LacI proteins. Of particular interest in future
studies will be examination of the effect of operator sequences with
altered spacing between half-sites on DNA binding parameters for these
proteins to determine whether insertion of Gly residues alters the
spacing of half-sites required for optimal binding.
 |
ACKNOWLEDGEMENTS |
We appreciate the technical assistance of
Emilia Mrowczynski, the provision of bacterial cell lines by Diane
Wycuff, feedback and discussion from the members of the Matthews
Laboratory, and the assistance of Dr. Tod D. Romo in rendering the structures.
 |
FOOTNOTES |
*
This work was supported by National Institutes of Health
Grant GM 22441 and Robert A. Welch Foundation Grant C-576 (to K. S. M.). Spectroscopic facilities utilized were provided by the Keck Center for Computational Biology and the Lucille P. Markey Charitable Trust.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed. Tel.: 713-527-4871;
Fax: 713-737-6149; E-mail, ksm@bioc.rice.edu.
1
D. Wycuff and K. S. Matthews, submitted for publication.
 |
ABBREVIATIONS |
The abbreviation used is:
IPTG, isopropyl-
,D-thiogalactoside.
 |
REFERENCES |
| 1.
|
Miller, J. H., and Reznikoff, W. S.
(eds)
(1980)
The Operon
, 2nd Ed.
, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
|
| 2.
|
Matthews, K. S.,
and Nichols, J. C.
(1998)
Prog. Nucleic Acids Res. Mol. Biol.
58,
127-164[Medline]
[Order article via Infotrieve]
|
| 3.
|
Deuschle, U.,
Gentz, R.,
and Bujard, H.
(1986)
Proc. Natl. Acad. Sci. U. S. A.
83,
4134-4137[Abstract/Free Full Text]
|
| 4.
|
Straney, S. B.,
and Crothers, D. M.
(1987)
Cell
51,
699-707[CrossRef][Medline]
[Order article via Infotrieve]
|
| 5.
|
Lee, J.,
and Goldfarb, A.
(1991)
Cell
66,
793-798[CrossRef][Medline]
[Order article via Infotrieve]
|
| 6.
|
Schlax, P. J.,
Capp, M. W.,
and Record, M. T., Jr.
(1995)
J. Mol. Biol.
245,
331-350[CrossRef][Medline]
[Order article via Infotrieve]
|
| 7.
|
Lewis, M.,
Chang, G.,
Horton, N. C.,
Kercher, M. A.,
Pace, H. C.,
Schumacher, M. A.,
Brennan, R. G.,
and Lu, P.
(1996)
Science
271,
1247-1254[Abstract]
|
| 8.
|
Gilbert, W.,
and Müller-Hill, B.
(1966)
Proc. Natl. Acad. Sci. U. S. A.
56,
1891-1898[Free Full Text]
|
| 9.
|
Riggs, A. D.,
and Bourgeois, S.
(1968)
J. Mol. Biol.
34,
361-364[CrossRef][Medline]
[Order article via Infotrieve]
|
| 10.
|
Friedman, A. M.,
Fischmann, T. O.,
and Steitz, T. A.
(1995)
Science
268,
1721-1726[Abstract/Free Full Text]
|
| 11.
|
Ogata, R. T.,
and Gilbert, W.
(1978)
Proc. Natl. Acad. Sci. U. S. A.
75,
5851-5854[Abstract/Free Full Text]
|
| 12.
|
Khoury, A. M.,
Nick, H. S.,
and Lu, P.
(1991)
J. Mol. Biol.
219,
623-634[CrossRef][Medline]
[Order article via Infotrieve]
|
| 13.
|
Zuiderweg, E. R. P.,
Scheek, R. M.,
Boelens, R.,
van Gunsteren, W. F.,
and Kaptein, R.
(1985)
Biochimie (Paris)
67,
707-715[Medline]
[Order article via Infotrieve]
|
| 14.
|
Kaptein, R.,
Slijper, M.,
and Boelens, R.
(1995)
Toxicol. Lett.
82/83,
591-599
|
| 15.
|
Chuprina, V. P.,
Rullmann, J. A. C.,
Lamerichs, R. M. J. N.,
van Boom, J. H.,
Boelens, R.,
and Kaptein, R.
(1993)
J. Mol. Biol.
234,
446-462[CrossRef][Medline]
[Order article via Infotrieve]
|
| 16.
|
Slijper, M.,
Bonvin, A. M. J. J.,
Boelens, R.,
and Kaptein, R.
(1996)
J. Mol. Biol.
259,
761-773[CrossRef][Medline]
[Order article via Infotrieve]
|
| 17.
|
Boelens, R.,
Scheek, R. M.,
van Boom, J. H.,
and Kaptein, R.
(1987)
J. Mol. Biol.
193,
213-216[CrossRef][Medline]
[Order article via Infotrieve]
|
| 18.
|
Geisler, N.,
and Weber, K.
(1977)
Biochemistry
16,
938-943[CrossRef][Medline]
[Order article via Infotrieve]
|
| 19.
|
Jovin, T. M.,
Geisler, N.,
and Weber, K.
(1977)
Nature
269,
668-672[CrossRef][Medline]
[Order article via Infotrieve]
|
| 20.
|
Bourgeois, S.,
and Pfahl, M.
(1976)
Adv. Protein Chem.
30,
1-99[Medline]
[Order article via Infotrieve]
|
| 21.
|
Chakerian, A. E.,
and Matthews, K. S.
(1991)
J. Biol. Chem.
266,
22206-22214[Abstract/Free Full Text]
|
| 22.
|
Chakerian, A. E.,
Tesmer, V. M.,
Manly, S. P.,
Brackett, J. K.,
Lynch, M. J.,
Hoh, J. T.,
and Matthews, K. S.
(1991)
J. Biol. Chem.
266,
1371-1374[Abstract/Free Full Text]
|
| 23.
|
Alberti, S.,
Oehler, S.,
von Wilcken-Bergmann, B.,
and Müller-Hill, B.
(1993)
EMBO J.
12,
3227-3236[Medline]
[Order article via Infotrieve]
|
| 24.
|
Alberti, S.,
Oehler, S.,
von Wilcken-Bergmann, B.,
Krämer, H.,
and Müller-Hill, B.
(1991)
New Biol.
3,
57-62[Medline]
[Order article via Infotrieve]
|
| 25.
|
Chen, J.,
and Matthews, K. S.
(1992)
J. Biol. Chem.
267,
13843-13850[Abstract/Free Full Text]
|
| 26.
|
Pace, H. C.,
Kercher, M. A.,
Lu, P.,
Markiewicz, P.,
Miller, J. H.,
Chang, G.,
and Lewis, M.
(1997)
Trends Biochem. Sci.
22,
334-339[CrossRef][Medline]
[Order article via Infotrieve]
|
| 27.
|
Suckow, J.,
Markiewicz, P.,
Kleina, L. G.,
Miller, J.,
Kisters-Woike, B.,
and Müller-Hill, B.
(1996)
J. Mol. Biol.
261,
509-523[CrossRef][Medline]
[Order article via Infotrieve]
|
| 28.
|
Schmitz, A.,
Schmeissner, U.,
Miller, J. H.,
and Lu, P.
(1976)
J. Biol. Chem.
251,
3359-3366[Abstract/Free Full Text]
|
| 29.
|
Daly, T. J.,
and Matthews, K. S.
(1986)
Biochemistry
25,
5474-5478[CrossRef][Medline]
[Order article via Infotrieve]
|
| 30.
|
Chang, W.-I.,
Olson, J. S.,
and Matthews, K. S.
(1993)
J. Biol. Chem.
268,
17613-17622[Abstract/Free Full Text]
|
| 31.
|
Spronk, C. A. E. M.,
Slijper, M.,
van Boom, J. H.,
Kaptein, R.,
and Boelens, R.
(1996)
Nat. Struct. Biol.
3,
916-919[CrossRef][Medline]
[Order article via Infotrieve]
|
| 32.
|
Kaptein, R.,
Zuiderweg, E. R. P.,
Scheek, R. M.,
Boelens, R.,
and van Gunsteren, W. F.
(1985)
J. Mol. Biol.
182,
179-182[CrossRef][Medline]
[Order article via Infotrieve]
|
| 33.
|
Wade-Jardetzky, N.,
Bray, R. P.,
Conover, W. W.,
Jardetzky, O.,
Geisler, N.,
and Weber, K.
(1979)
J. Mol. Biol.
128,
259-264[CrossRef][Medline]
[Order article via Infotrieve]
|
| 34.
|
Geisler, N.,
and Weber, K.
(1978)
FEBS Lett.
87,
215-218[CrossRef][Medline]
[Order article via Infotrieve]
|
| 35.
|
Files, J. G.,
and Weber, K.
(1976)
J. Biol. Chem.
251,
3386-3391[Abstract/Free Full Text]
|
| 36.
|
Platt, T.,
Files, J. G.,
and Weber, K.
(1973)
J. Biol. Chem.
248,
110-121[Abstract/Free Full Text]
|
| 37.
|
Spolar, R. S.,
and Record, M. T., Jr.
(1994)
Science
263,
777-784[Abstract/Free Full Text]
|
| 38.
|
Schumacher, M. A.,
Choi, K. Y.,
Zalkin, H.,
and Brennan, R. G.
(1994)
Science
266,
763-770[Abstract/Free Full Text]
|
| 39.
|
Schumacher, M. A.,
Choi, K. Y.,
Lu, F.,
Zalkin, H.,
and Brennan, R. G.
(1995)
Cell
83,
147-155[CrossRef][Medline]
[Order article via Infotrieve]
|
| 40.
|
Nagadoi, A.,
Morikawa, S.,
Nakamura, H.,
Enari, M.,
Kobayashi, K.,
Yamamoto, H.,
Sampei, G.,
Mizobuchi, K.,
Schumacher, M. A.,
Brennan, R. G.,
and Nishimura, Y.
(1995)
Structure
3,
1217-1224[Medline]
[Order article via Infotrieve]
|
| 41.
|
Härd, T.,
Kellenbach, E.,
Boelens, R.,
Maler, B. A.,
Dahlman, K.,
Freedman, L. P.,
Carlstedt-Duke, J.,
Yamamoto, K. R.,
Gustafsson, J.-A.,
and Kaptein, R.
(1990)
Science
249,
157-160[Abstract/Free Full Text]
|
| 42.
|
Luisi, B. F.,
Xu, W. X.,
Otwinowski, Z.,
Freedman, L. P.,
Yamamoto, K. R.,
and Sigler, P. B.
(1991)
Nature
352,
497-505[CrossRef][Medline]
[Order article via Infotrieve]
|
| 43.
|
Saudek, V.,
Pasley, H. S.,
Gibson, T.,
Gausepohl, H.,
Frank, R.,
and Pastore, A.
(1991)
Biochemistry
30,
1310-1317[CrossRef][Medline]
[Order article via Infotrieve]
|
| 44.
|
Dickerson, R. E.,
and Chiu, T. K.
(1997)
Biopolymers
44,
361-403[CrossRef][Medline]
[Order article via Infotrieve]
|
| 45.
|
Kleina, L. G.,
and Miller, J. H.
(1990)
J. Mol. Biol.
212,
295-318[CrossRef][Medline]
[Order article via Infotrieve]
|
| 46.
|
Markiewicz, P.,
Kleina, L. G.,
Cruz, C.,
Ehret, S.,
and Miller, J. H.
(1994)
J. Mol. Biol.
240,
421-433[CrossRef][Medline]
[Order article via Infotrieve]
|
| 47.
|
Müller-Hill, B.
(1975)
Prog. Biophys. Mol. Biol.
30,
227-252[Medline]
[Order article via Infotrieve]
|
| 48.
|
Buck, F.,
Rüterjans, H.,
and Beyreuther, K.
(1978)
FEBS Lett.
96,
335-338[CrossRef][Medline]
[Order article via Infotrieve]
|
| 49.
|
Chou, P. Y.,
and Fasman, G. D.
(1974)
Biochemistry
13,
211-222[CrossRef][Medline]
[Order article via Infotrieve]
|
| 50.
|
Sibanda, B. L.,
and Thornton, J. M.
(1985)
Nature
316,
170-174[CrossRef][Medline]
[Order article via Infotrieve]
|
| 51.
|
O'Gorman, R. B.,
Dunaway, M.,
and Matthews, K. S.
(1980)
J. Biol. Chem.
255,
10100-10106[Abstract/Free Full Text]
|
| 52.
|
Barry, J. K.,
and Matthews, K. S.
(1997)
Biochemistry
36,
15632-15642[CrossRef][Medline]
[Order article via Infotrieve]
|
| 53.
|
Bourgeois, S.
(1971)
Methods Enzymol.
21,
491-500
|
| 54.
|
Laiken, S. L.,
Gross, C. A.,
and von Hippel, P. H.
(1972)
J. Mol. Biol.
66,
143-155[CrossRef][Medline]
[Order article via Infotrieve]
|
| 55.
|
O'Gorman, R. B.,
Rosenberg, J. M.,
Kallai, O. B.,
Dickerson, R. E.,
Itakura, K.,
Riggs, A. D.,
and Matthews, K. S.
(1980)
J. Biol. Chem.
255,
10107-10114[Abstract/Free Full Text]
|
| 56.
|
Riggs, A. D.,
Bourgeois, S.,
Newby, R. F.,
and Cohn, M.
(1968)
J. Mol. Biol.
34,
365-368[CrossRef][Medline]
[Order article via Infotrieve]
|
| 57.
|
Wong, I.,
and Lohman, T. M.
(1993)
Proc. Natl. Acad. Sci. U. S. A.
90,
5428-5432[Abstract/Free Full Text]
|
| 58.
|
Capp, M. W.,
Cayley, D. S.,
Zhang, W.,
Guttman, H. J.,
Melcher, S. E.,
Saecker, R. M.,
Anderson, C. F.,
and Record, M. T., Jr.
(1996)
J. Mol. Biol.
258,
25-36[CrossRef][Medline]
[Order article via Infotrieve]
|
| 59.
|
Frank, D. E.,
Saecker, R. M.,
Bond, J. P.,
Capp, M. W.,
Tsodikov, O. V.,
Melcher, S. E.,
Levandoski, M. M.,
and Record, M. T., Jr.
(1997)
J. Mol. Biol.
267,
1186-1206[CrossRef][Medline]
[Order article via Infotrieve]
|
| 60.
|
Presta, L. G.,
and Rose, G. D.
(1988)
Science
240,
1632-1641[Abstract/Free Full Text]
|
| 61.
|
Richardson, J. S.,
and Richardson, D. C.
(1988)
Science
240,
1648-1652[Abst |